TERT promoter mutations and monoallelic activation of TERT in cancer

Oncogenesis

Volumn 4, Issue , 2015, Pages

  Huang, F W ^a,b,c   Bielski, C M ^c   Rinne, M L ^a,b,c   Hahn, W C ^a,b,c   Sellers, W R ^d   Stegmeier, F ^b   Garraway, L A ^a,b,c   Kryukov, G V ^a,c,e  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ALLELE; ALLELIC IMBALANCE; ARTICLE; CANCER CELL LINE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; NEOPLASM; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RNA SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION;

EID: 84949788402     PISSN: None     EISSN: 21579024     Source Type: Journal    
DOI: 10.1038/oncsis.2015.39     Document Type: Article

References (20)

1. Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA. Highly recurrent TERT promoter mutations in human melanoma. Science 2013; 6122: 957-959.
2. Horn S, Figl A, Rachakonda PS, Fischer C, Sucker A, Gast A et al. TERT promoter mutations in familial and sporadic melanoma. Science 2013; 6122: 959-961.
3. Killela PJ, Reitman ZJ, Jiao Y, Bettegowda C, Agrawal N, Diaz LA Jr et al. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci USA 2013; 15: 6021-6026.
4. Vinagre J, Almeida A, Pópulo H, Batista R, Lyra J, Pinto V et al. Frequency of TERT promoter mutations in human cancers. Nat Commun 2013; 4: 2185.
5. Heidenreich B, Rachakonda PS, Hemmink K, Kumar R. TERT promoter mutations in cancer development. Curr Opin Genet Dev 2014; 24: 30-37.
6. Borah S, Xi L, Zaug AJ, Powell NM, Dancik GM, Cohen SB et al. TERT promoter mutations and telomerase reactivation in urothelial cancer. Science 2015; 6225: 1006-1010.
7. Bell RJ, Rube HT, Kreig A, Mancini A, Fouse SD, Nagarajan RP et al. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer. Science 2015; 6238: 1036-1039.
8. Chiba K, Johnson JZ, Vogan JM, Wagner T, Boyle JM, Hockemeyer D. Cancer-associated TERT promoter mutations abrogate telomerase silencing. eLife 2015; 4: e07918.
9. Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 2012; 7391: 603-607.
10. CGHub data repository. Available at: https://cghub.ucsc.edu/datasets/ccle.html (last accessed on May 2015).
11. Eckersley-Maslin MA, Thybert D, Bergmann JH, Marioni JC, Flicek P, Spector DL. Random monoallelic gene expression increases upon embryonic stem cell differentiation. Dev Cell 2014; 28: 351-365.
12. Weinhold N, Jacobsen A, Schultz N, Sander C, Lee W. Genome-wide analysis of noncoding regulatory mutations in cancer. Nat Genet 2014; 46: 1160-1165.
13. Fredriksson NJ, Ny L, Nilsson JA, Larsson E. Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types. Nat Genet 2014; 46: 1258-1263.
14. Melton C, Reuter JA, Spacek DV, Snyder M. Recurrent somatic mutations in regulatory regions of human cancer genomes. Nat Genet 2015; 47: 710-716.
15. Gimelbrant A, Hutchinson JN, Thompson BR, Chess A. Widespread monoallelic expression on human autosomes. Science 2007; 5853: 1136-1140.
16. Eckersly-Maslin MA, Spector DL. Random monoallelic expression: regulating gene expression one allele at a time. Trends Genet 2015; 6: 237-244.
17. Castelo-Branco P, Choufani S, Mack S, Gallagher D, Zhang C, Lipman T et al. Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study. Lancet Oncol 2013; 6: 534-542.
18. Smith KS, Yadav VK, Pedersen BS, Shaknovich R, Geraci MW, Pollard KS et al. Signatures of accelerated somatic evolution in gene promoters in multiple cancer types. Nucleic Acids Res 2015; 11: 5307-5317.
19. Mathelier A, Lefebvre C, Zhang AW, Arenillas DJ, Ding J, Wasserman WW et al. Cis-regulatory somatic mutations and geneexpression alteration in B-cell lymphomas. Genome Biol 2015; 17: 1966-1967.
20. Katainen R, Dave K, Pitkänen E, Palin K, Kivioja T, Välimäki N et al. CTCF/cohesin-binding sites are frequently mutated in cancer. Nat Genet 2015; 47: 818-821.